Compare Cassava Sciences Inc (FLNA) vs Palantir Technologies Inc (PLTR) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Palantir (PLTR) trades at $133.01, down 0.53% on the day, showing resilience near key support at $133 after recent volatility. The stock maintains a bullish technical trend with strong moving average signals, while fundamentals reveal explosive growth with 2025 revenue reaching $4.48 billion and net income surging to $1.63 billion. Recent partnerships with Nvidia and consistent earnings beats highlight ongoing business momentum, though valuation multiples remain elevated at 150x P/E and 66x P/S ratios.

The outlook remains positive given strong earnings trajectory and AI infrastructure demand, with analyst consensus target at $185.75 suggesting 40% upside potential. Primary risks include premium valuation sensitivity, competitive pressures in AI software, and execution challenges in sustaining high growth rates. Second quarter 2026 earnings on August 3 will be critical for validating current momentum.